Avita Medical | 1811094D - 债务



金融业
股票价格
AUD
资产
AUD 56.39M
现金及等价物
AUD 10.24M
销售成本
AUD 3.3M
流动资产
AUD 35.49M
流动负债
AUD 62.68M
债务
AUD 46.05M
EBIT
AUD -10.39M
EBITDA
AUD -9.69M
员工
AUD 87
EPS每股收益
AUD -0.38
股本和储备
AUD -16.65M
销售毛利
AUD 14.31M
债务利息支出
AUD 1.25M
贷款资金
AUD 42.25M
市值
AUD 377.91M
净收入
AUD -11.62M
营业费用
AUD 28.02M
营业利润
AUD -10.41M
税前利润
AUD -11.64M
销售收入
AUD 17.62M
销售和管理费用
AUD 19.03M
股票
AUD 6.93M
贸易债权人
AUD 8.96M
应收帐款人
AUD 9.11M


债务 更改 日
Accuray USD 170.24M 4.52M 2024-09
Celltrion KRW 160.58B 733.3M 2026-03
Clinuvel Pharmaceuticals AUD 879.78K 189.09K 2024-06
Cochlear AUD 235.7M 10.9M 2025-06
CSL USD 11.96B 219M 2024-12
Cspc Pharmaceutical CNY 641.11M 146.11M 2025-12
Deva Holding AS TRY 5.3B 871.93M 2023-09
Dianthus Therapeutics USD 1.36M 79K 2026-03
Divis Laboratories Ltd INR 70M 30M 2026-03
Kangmei Pharma CNY 173.71M 42.08M 2026-03
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Laboratorios Farma EUR 129.3M 14.89M 2025-06
Malin Corporation EUR 100K 0 2023-12
Mayne Pharma AUD 38.82M 2.24M 2024-06
Medical Developments International AUD 1.99M 152K 2025-06
Nanosonics AUD 7.69M 1.49M 2025-06
Neuren Pharmaceuticals AUD 0 0 2024-12
Organigram Holdings CAD 8.2M 554K 2026-03
Ovoca Bio EUR 0 0 2021-06
Pacific Edge NZD 2.9M 425K 2025-03
Paradigm Biopharmaceuticals AUD 181.4K 38.99K 2024-12
Pharma Mar EUR 45.84M 1.7M 2026-06
Polynovo AUD 15.38M 49K 2024-06
PYC Therapeutics AUD 1.02M 185.07K 2025-06
Qiagen NV USD 1.65B 165.82M 2026-03
Ramsay Health Care AUD 12.12B 864.4M 2025-06
ResMed USD 843.17M 3.18M 2026-03
Sartorius EUR 4.05B 248.8M 2026-06
Sino Biopharmaceutical CNY 9.71B 33.98M 2024-12
Telix Pharmaceuticals AUD 467.11M 48.85M 2025-12
Tilray USD 640.95M 35.17M 2022-06
Zealand Pharma A/S 414M 8.23M 2026-03
Zz Pientze Pharmaceu CNY 1.07B 2.82M 2026-03